DigiPath, Olympus ink digital pathology deal

DigiPath and Olympus America have entered into a nonexclusive global agreement allowing DigiPath and its partners to access a portfolio of Olympus patents in the field of virtual microscopy and digital pathology.

The patents involved in the licensing agreement cover methods, software and technology for creating, storing and delivering virtual microscopy images, said Henderson, Nev.-based DigiPath, a digital pathology provider, and Center Valley, Pa.-based Olympus, which provides life science imaging systems.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.